Early Metoprolol Administration Before Coronary Reperfusion Results in Increased Myocardial Salvage
about
sameAs
ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotectionReducing myocardial infarct size: challenges and future opportunitiesCardiovascular imaging: what have we learned from animal models?Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discoveryRemote ischaemic conditioning in the context of type 2 diabetes and neuropathy: the case for repeat application as a novel therapy for lower extremity ulcerationThe emerging clinical role of cardiovascular magnetic resonance imaging.Neutrophil stunning by metoprolol reduces infarct sizeQuantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance.Novel adjunctive treatments of myocardial infarction.Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations.Cardioprotective Effects of Astragalin against Myocardial Ischemia/Reperfusion Injury in Isolated Rat Heart.Stimulating myocardial regeneration with periostin Peptide in large mammals improves function post-myocardial infarction but increases myocardial fibrosisImpact of left ventricular hypertrophy on troponin release during acute myocardial infarction: new insights from a comprehensive translational study.CMR imaging of edema in myocardial infarction using cine balanced steady-state free precession.Quantitative T 2* assessment of acute and chronic myocardial ischemia/reperfusion injury in miceQuantifying the Area at Risk in Reperfused ST-Segment-Elevation Myocardial Infarction Patients Using Hybrid Cardiac Positron Emission Tomography-Magnetic Resonance Imaging.Non-ST elevation myocardial infarction (NSTEMI) in three hospital settings in South Africa: does geography influence management and outcome? A retrospective cohort study.The adult Göttingen minipig as a model for chronic heart failure after myocardial infarction: focus on cardiovascular imaging and regenerative therapies.Cardiac MRI of myocardial salvage at the peri-infarct border zones after primary coronary interventionSafety of intravenous ivabradine in acute ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention: a randomized, placebo-controlled, double-blind, pilot studyTargeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations.The future: therapy of myocardial protection.Cardioprotection and pharmacological therapies in acute myocardial infarction: Challenges in the current era.Treatment of ST-elevation myocardial infarction.Early intravenous beta-blockers in patients with acute coronary syndrome--a meta-analysis of randomized trials.Allogenic adipose-derived stem cell therapy overcomes ischemia-induced microvessel rarefaction in the myocardium: systems biology study.The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusionUsing magnetic resonance imaging to characterize recent myocardial injury: utility in acute coronary syndrome and other clinical scenarios.Cardiotoxicity of mycotoxin citrinin and involvement of microRNA-138 in zebrafish embryos.Routine beta-blocker administration following acute myocardial infarction: why still an unsolved issue?Guidelines for translational research in heart failure.Ivabradine vs metoprolol in patients with acute inferior wall myocardial infarction-"Expanding arena for ivabradine".Top 10 cardiovascular therapies and interventions for the next decade.Guidelines for Experimental Models of Myocardial Ischemia and Infarction.Antiarrhythmic activity in occlusion-reperfusion model of 1-(1H-indol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino} propan-2-ol and its enantiomers.β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes.Stromal cell derived factor-1 (SDF-1) targeting reperfusion reduces myocardial infarction in isolated rat hearts.Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotectionAnimal Models of Tissue Characterization of Area at Risk, Edema and Fibrosis
P2860
Q24289195-880ACC99-CECB-4E95-A864-0BFCB1A6D32AQ26750797-5B5534FF-281F-47E3-8C57-BE04E2277E11Q26775395-B0A14658-47E7-40DE-9E93-F3B5B3C0C664Q26779676-5DB14023-4205-46E4-9FF3-766F7A6C9A01Q28072918-7325DED6-B50C-4D83-BE7B-B31F1E3097ABQ28078462-4FC13C8E-5B5A-4EA9-AC2F-41EB8EF84D8BQ30475257-3CF33CF9-AFF4-4D64-A7D3-65FFBF27D174Q33587119-5C4D451E-3C0E-49BF-A636-21F487C3064BQ33720141-828643F8-F8C1-4D22-91BB-9E646D03E0A5Q33812924-48339C06-3F82-48BA-8DEA-2A5733DD360BQ34247485-87B9F465-1FEC-4D44-882C-C4F354B189F8Q34675305-CD4FEBC4-12E6-4A99-990A-FDD33FDA3075Q34734901-5EDF6D06-C76A-44E2-BABA-8879AA4ADFF7Q35088064-C19140F2-C22F-4660-8203-80778B0C6B32Q35724779-6A29DF31-4848-40DA-A8DB-DCBE4A4588E2Q36279421-0D165ACD-FB08-49B2-A749-0D43679B60D8Q36783710-926A6E33-779E-4FB9-9FA1-7BA8FA593FE0Q37041708-B74A3568-70A7-4DCC-B179-9B86E4774157Q37261974-E54C0A3D-509E-4E8A-BF2E-B177A54888C1Q37264368-2A2D96B3-B267-46FA-B5D6-C251949A3C34Q37291884-CF5131B1-449A-43A6-8717-9AE88955020AQ37738596-DEB0E188-1A21-4A8F-BD3B-891AADCF04F8Q38006737-9C4D4448-33D8-48CD-8373-2FE9651A21AEQ38199493-55AC1B85-87B9-428E-B3FE-5EFA0D6CB273Q40076747-68B64CF1-43CE-49C2-842A-F9598775CFDAQ41971777-BA9ED3D2-DD0D-40E9-9977-DF0DDBB2D8DEQ41997489-F9EA27B6-AAEE-411C-85C9-2CCDB7904FEAQ42559928-03AD72AC-F3BF-43FC-9AEB-0EFFC7EE5DBBQ42587043-DC1A1B08-468F-4EC7-A2C1-11878274B57AQ42709337-6EF5435B-2665-4FE9-99AA-9E44F0BEF423Q47138444-F641053D-2373-42A7-98E0-B6C8056D991BQ47573464-4A115D67-AFC6-4370-ACF3-797AB4EF0992Q48257897-C6B0C9D1-D1C5-473D-A4E9-2D3D106B6AD7Q48778308-EF118C3B-98D9-457D-956C-29126F9964F7Q49917885-BFABD524-928F-4259-9E22-AF9EAA7B31D1Q52149069-64D803E2-6178-4435-B17B-9A1F4D5775F3Q54343158-D8826116-3CE5-4F8F-A3C6-0C7A8A179418Q54485510-3D60FA39-000C-4938-B73F-88E0C8514CECQ57760906-904112CD-CC10-42ED-ADFC-0A79DF4BCE8FQ57761241-07480761-0E12-438F-8E10-99B2CDF4CFEA
P2860
Early Metoprolol Administration Before Coronary Reperfusion Results in Increased Myocardial Salvage
description
article
@en
im Juni 2007 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2007
@uk
name
Early Metoprolol Administratio ...... n Increased Myocardial Salvage
@en
Early Metoprolol Administratio ...... n Increased Myocardial Salvage
@nl
type
label
Early Metoprolol Administratio ...... n Increased Myocardial Salvage
@en
Early Metoprolol Administratio ...... n Increased Myocardial Salvage
@nl
altLabel
Early metoprolol administratio ...... ing cardiac magnetic resonance
@en
Early metoprolol administratio ...... ing cardiac magnetic resonance
@nl
prefLabel
Early Metoprolol Administratio ...... n Increased Myocardial Salvage
@en
Early Metoprolol Administratio ...... n Increased Myocardial Salvage
@nl
P2093
P50
P1433
P1476
Early metoprolol administratio ...... ing cardiac magnetic resonance
@en
P2093
Antonio Pinero
Gemma Vilahur
Javier Sanz
Juan J Badimon
Mario J García
P304
P356
10.1161/CIRCULATIONAHA.106.679639
P407
P577
2007-05-21T00:00:00Z